Skip to main content

Advertisement

Table 3 Unadjusted potential predictors of treatment completion among the study population (n = 93)

From: Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

  Number completed treatment (%; n = 71 Number not completing treatment (%; n = 22) Unadjusted OR 95% CI P
Age (years)
  ≤ 41 38 (83) 8 (17) 1.00 - -
  > 41 33 (70) 14 (30) 0.50 0.19–1.33 0.164
Gender
 Female 13 (81) 3 (19) 1.00 - -
 Male 58 (75) 19 (25) 0.70 0.18–2.74 0.613
Educationa
  < Tertiary 52 (79) 14 (21) 1.00 - -
 Tertiary or greater 18 (75) 6 (25) 0.81 0.27–2.42 0.703
Social functioning score    
  < 17 31 (78) 9 (23) 1.00 - -
  ≥ 17 40 (75) 13 (25) 0.89 0.34–2.36 0.820
Stable housing
 No 17 (77) 5 (23) 1.00 - -
 Yes 54 (76) 17 (24) 0.93 0.30–2.91 0.907
Current depressionb
 No 30 (75) 10 (25) 1.00 - -
 Yes 37 (80) 9 (20) 1.37 0.49–3.80 0.545
Hazardous alcohol consumptionc
 No 58 (81) 14 (19) 1.00 - -
 Yes 11 (83) 2 (15) 1.71 0.35–8.43 0.512
Current OST
 No 19 (70) 8 (30) 1.00 - -
 Yes 52 (79) 14 (21) 1.56 0.57–4.32 0.388
Injecting (last month)
 No 26 (68) 12 (32) 1.00 - -
 Yes 45 (82) 10 (18) 2.08 0.79–5.47 0.139
Frequency of injecting (last month)
 Never 26 (68) 12 (32) 1.00 - -
 Less than weekly 17 (77) 5 (23) 1.57 0.47–5.26 0.465
 Weekly or greater 28 (85) 5 (15) 2.58 0.80–8.34 0.112
Heroin injecting (last month)
 No 43 (72) 17 (28) 1.00 - -
 Yes 28 (85) 5 (15) 2.21 0.73–6.68 0.159
Cocaine injecting (last month)
 No 63 (76) 20 (24) 1.00 - -
 Yes 8 (80) 2 (20) 1.27 0.25–6.48 0.774
Amphetamine injecting (last month)
 No 63 (80) 16 (20) 1.00 - -
 Yes 8 (57) 6 (43) 0.34 0.10–1.12 0.075
Injecting on therapy
 No 30 (83) 6 (17) 1.00 - -
 Yes 41 (79) 11 (21) 0.75 0.25–2.24 0.601
Therapy duration*
 24 weeks 13 (50) 13 (50) 1.00 - -
 12 weeks 58 (95) 3 (5) 19.33 4.81–77.78 <0.001
  1. *Among participants who attended study week 4
  2. aMissing data for three participants
  3. bMissing data for seven participants
  4. cMissing data for eight participants; percentages refer to row percentages